Related Experiment Video
Updated: Jan 7, 2026

07:17
Single Port Donor Nephrectomy
Published on: March 12, 2011
52.2K
Single-Port Partial Nephrectomy: State of the Art and Future Directions
Lorenzo Santodirocco1,2, Luca A Morgantini3, Marwan Alkassis3
1Department of Urology, University of Illinois at Chicago, Chicago, Illinois, USA, lorenzo.santodirocco@uniroma1.it.
Urologia Internationalis
|December 26, 2025
Summary
Single-Port Robot-Assisted Partial Nephrectomy (SP-RAPN) provides outcomes comparable to Multi-Port RAPN (MP-RAPN) while enhancing minimally invasive surgery. This approach offers improved recovery and cosmetic results, making it a safe evolution for localized renal masses.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Partial Nephrectomy (PN) is the standard for localized renal masses, with robotic surgery enhancing minimally invasive approaches.
- Single-Port (SP) robotic systems aim to reduce invasiveness and improve recovery through a single incision.
- SP-RAPN has shown early promise, with results comparable to Multi-Port (MP) robotic surgery.
Purpose of the Study:
- To evaluate the efficacy and safety of Single-Port Robot-Assisted Partial Nephrectomy (SP-RAPN).
- To compare SP-RAPN outcomes with traditional Multi-Port RAPN (MP-RAPN).
- To explore the benefits of specific surgical approaches like the retroperitoneal route and Lower Anterior Access (LAA).
Main Methods:
- Comparative analysis of SP-RAPN and MP-RAPN perioperative, oncological, and functional outcomes.
- Evaluation of different surgical access routes, including retroperitoneal and LAA.
- Review of early experiences and technological advancements impacting SP-RAPN.
Main Results:
- SP-RAPN demonstrates comparable oncological and functional results to MP-RAPN.
- SP-RAPN offers advantages in reduced invasiveness, improved cosmetic outcomes, and shorter hospital stays.
- Retroperitoneal and LAA approaches show anesthesiological and surgical benefits, though SP-RAPN may have slightly longer Warm Ischemia Times (WITs).
Conclusions:
- SP-RAPN is a safe and feasible advancement in nephron-sparing surgery.
- The retroperitoneal and LAA approaches enhance perioperative benefits.
- Patient selection, training, and technological advancements are key to optimizing SP-RAPN's role in urologic surgery.

